does medicaid cover glp-1 Drugs? A State-by-State Guide — StateVitals California Medi-Cal halts GLP-1 obesity

Many autoimmune conditions have gut involvement, whether through intestinal permeability (leaky gut), microbiome disruption, or direct intestinal immune activation

**Disclaimer: The people interviewed above are not Ro patients and are not affiliated with Ro Health

Increasing evidence has demonstrated that GLP-1 analogues can cross the blood-brain barrier, protect dopaminergic neurons in the substantia nigra, and rescue motor activity and cognitive functions in PD animal models (5961)

5F) [19]

A 2024 study published in JAMA Ophthalmology found an increased risk of NAION for those taking semaglutide medications

This federal litigation is for people who say Wegovy (or another GLP-1 drug) contributed to them developing NAION